GlaxoSmithKline PLC ADR (GSK) stock chart and technical analysis
Indicator summary: Bearish (0 bullish, 4 bearish, 1 neutral). As of 2026-10-07, the close was $47.02: 6.3% below the 50-day average and 9.0% below the 200-day average, which is rising. RSI (14) is 36, in its neutral range. MACD is bearish after a cross in the last 10 days. The stock sits 30% of the way up its 52-week range of $41.36 to $60.09, on 1.6x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $50.17 | Price 6.3% below |
| 200-day average | $51.67 | Price 9.0% below, average rising |
| 50 vs 200-day | 50 below 200 | Death-cross alignment |
| RSI (14) | 36 | Neutral range |
| MACD (12, 26, 9) | -0.94 vs -0.65 | Bearish cross in the last 10 days |
| 52-week range | $41.36 to $60.09 | 30% of the way up the range |
| Volume vs 20-day average | 1.6x | Heavy |
What followed this setup for GSK
- When it closed below its 200-day average (2,445 days), it was higher 63 trading days later 61% of the time, median +2.4%.
- When it closed below its 50-day average (2,864 days), it was higher 63 trading days later 61% of the time, median +2.4%.
- When it had MACD below its signal line (3,382 days), it was higher 63 trading days later 57% of the time, median +1.3%.
- All days since 1999 (6,711 days): higher 63 trading days later 57% of the time, median +1.4%.
Base rates use GSK's own daily history since 1999; they describe the past, not a forecast.
Questions about GSK's chart
What is GSK's RSI today?
As of 2026-10-07, GSK's 14-day RSI is 36, which is in the neutral range between 30 and 70.
Is GSK above its 200-day moving average?
No. GSK closed at $47.02 on 2026-10-07, 9.0% below its 200-day average of $51.67, which is rising. When it closed below its 200-day average (2,445 days), it was higher 63 trading days later 61% of the time, median +2.4%.
Is GSK above its 50-day moving average?
No. GSK closed at $47.02 on 2026-10-07, 6.3% below its 50-day average of $50.17. When it closed below its 50-day average (2,864 days), it was higher 63 trading days later 61% of the time, median +2.4%.
Has GSK had a MACD crossover?
Yes, a bearish cross within the last 10 trading days. As of 2026-10-07 the MACD line is -0.94 against a signal line of -0.65, so MACD is bearish.
Is GSK near its 52-week high?
No. At $47.02 it sits 30% of the way up its 52-week range of $41.36 to $60.09, 21.8% below the high.
What is GSK's technical rating today?
Bearish: 0 of 5 indicators are bullish and 4 bearish as of 2026-10-07 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Buy, from the chart signal model.
GSK analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.